Login

Suven Pharmaceuticals Ltd.

₹1081.7

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Suven Pharmaceuticals Ltd.

₹1081.7

₹1081.7

28.45 (2.7%) - 8 Apr 2025 04:26 PM

About Company

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Market Cap. ₹26,812 Cr.
52 Week - High/Low ₹1,360/598
P/E Ratio 95.32
P/B Ratio 13.04
Enterprise Value ₹26,870 Cr.
ROE % 16.03
RSI Value 92.39
EMA 50 1076.33
EMA 200 1074.67
Net Profit 305 Cr.
Net Profit 3year growth -1.24 Cr.
Net Profit 3 year (back) 309 Cr.
Debt to Equity 0.02 %
EPS Growth TTM -26.28 %
Current Ratio 6.42 %
100 Day SMA 1,159 Rs.
200 Day SMA 1,111 Rs.
21 Day SMA 1,139 Rs.
50 Day SMA 1,127 Rs.
Book Value 81 Rs.
EV/EBITDA Ratio 62
QoQ EPS Growth 13 %
QoQ Operating Profit Growth 14 %
QoQ Sales Growth 17 %
Sales Latest Quarter 275 Cr.
YoY Sales Growth 29 %
Market Cap. ₹26,812 Cr.
52 Week - High/Low ₹1,360/598
P/E Ratio 95.92
P/B Ratio 13.07
Enterprise Value ₹26,858 Cr.
ROE % 15.87
RSI Value 92.39
EMA 50 1076.33
EMA 200 1074.67
Net Profit 300 Cr.
Net Profit 3year growth -2.37 Cr.
Net Profit 3 year (back) 362 Cr.
Debt to Equity 0.02 %
EPS Growth TTM -24.64 %
Current Ratio 6.61 %
100 Day SMA 1,159 Rs.
200 Day SMA 1,111 Rs.
21 Day SMA 1,139 Rs.
50 Day SMA 1,127 Rs.
Book Value 81 Rs.
EV/EBITDA Ratio 61
QoQ EPS Growth 1 %
QoQ Operating Profit Growth 13 %
QoQ Sales Growth 19 %
Sales Latest Quarter 307 Cr.
YoY Sales Growth 40 %
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.